Parker Geoffrey M.
SEC Form 4 insider trading activity
Parker Geoffrey M. has filed 6 SEC Form 4 filings (9 transaction rows) across 2 companies, including PRGO, ALLO, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Parker Geoffrey M. is listed as CHIEF FINANCIAL OFFICER at Allogene Therapeutics, Inc. Inside the rolling window, Parker Geoffrey M. reported 1 open-market purchase totaling $106K in PRGO and 2 open-market sales totaling $88K in ALLO. The largest disclosed transaction in the window is a purchase of 7,500 PRGO shares on Nov 12, 2025, worth $106K.
Companies traded
Other insiders at PRGO
Insider Buying
$106K
reported purchases (SEC code P)
Insider Selling
$88K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Parker Geoffrey M. made?
Parker Geoffrey M. has filed 6 SEC Form 4 filings (9 transaction rows) across 2 companies, including PRGO, ALLO since 2025.
Which companies does Parker Geoffrey M. trade?
Parker Geoffrey M. has filed SEC Form 4 disclosures for 2 companies, including PRGO, ALLO.
When was Parker Geoffrey M.'s most recent SEC Form 4 filing?
Parker Geoffrey M.'s most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Parker Geoffrey M.'s total buy and sell value in the current window?
Inside the rolling retention window, Parker Geoffrey M. bought $106K and sold $88K based on SEC Form 4 filings.
What was Parker Geoffrey M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 7,500 PRGO shares on 2025-11-12, worth $106K, per SEC Form 4 filings.